Press Release

DBRS Morningstar Confirms Rating on Class A-1 Notes Issued by Ares XXXIR CLO Ltd.

Structured Credit
December 21, 2022

DBRS, Inc. (DBRS Morningstar) confirmed its rating of AAA (sf) on the Class A-1 Notes issued by Ares XXXIR CLO Ltd. as the Issuer and Ares XXXIR CLO LLC as the Co-Issuer (together, with the Issuer, the Co-Issuers).

The rating on the Class A-1 Notes (the Notes) was issued pursuant to the Indenture, dated as of May 24, 2018, among Ares XXXIR CLO Ltd., as the Issuer; Ares XXXIR CLO LLC, as the Co-Issuer; and U.S. Bank National Association (rated AA (high) with a Stable trend by DBRS Morningstar), as the Trustee.

The rating on the Notes addresses the timely payment of interest and the ultimate payment of principal in accordance with the terms of the Indenture referred to above.

The Notes issued by the Co-Issuers are collateralized primarily by a portfolio of U.S. senior secured floating-rate broadly syndicated corporate loans. The collateralized loan obligation (CLO) is managed by Ares CLO Management, LLC (Ares), an affiliate of Ares Management Corporation, as the Asset Manager. DBRS Morningstar considers Ares to be an acceptable CLO manager.

The rating action is a result of the annual surveillance review of the transaction. DBRS Morningstar confirmed the rating on the Notes as the current transaction performance is within DBRS Morningstar’s expectation. The Stated Maturity is May 24, 2030. The Reinvestment Period ends on May 24, 2023.

In its analysis, DBRS Morningstar considered the following aspects of the transaction:

(1) DBRS Morningstar’s application of its DBRS Morningstar CLO Methodologies, which set forth key analytical considerations and applicable analytics used when DBRS Morningstar assigns and monitors credit ratings.
(2) The transaction’s capital structure and the form and sufficiency of available credit enhancement.
(3) Relevant credit enhancement in the form of subordination and excess spread.
(4) The ability of the Notes to withstand projected collateral loss rates under various cash flow stress scenarios.
(5) The credit quality of the underlying collateral and the ability of the transaction to reinvest Principal Proceeds into new Collateral Obligations, subject to the Eligibility Criteria, which include testing the Concentration Limitations, Collateral Quality Tests, and Coverage Tests.
(6) DBRS Morningstar’s assessment of the origination, servicing, and CLO management capabilities of Ares as the Collateral Manager.

The transaction has a dynamic structural configuration that is used to determine which of the row/column combinations (each, a Matrix Case) are applicable for the purpose of determining compliance with the Minimum Diversity/Maximum Weighted-Average (WA) Rating/Minimum WA Spread Matrix (Matrix), as defined in the Indenture. Depending on a given Diversity Score, the following metrics are selected accordingly from the applicable row of the Asset Quality Matrix: WA Spread, WA Rating. DBRS Morningstar converted the WA Rating constraints to the DBRS Morningstar Risk Score using linear interpolation and analyzed each structural configuration as a unique transaction. The Collateral Quality Tests that DBRS Morningstar modeled during its analysis are presented below:

(1) WA Spread Test: 3.39%
(2) Minimum WA Moody’s Recovery Rate Test: 43.0%
(3) WA Coupon Test: 7.0%
(4) Diversity Test: 80
(5) WA Rating Test: 3035
(6) WA Life Test: 4.50

Some particular strengths of the transaction are: (1) collateral quality that consists of at least 96% senior-secured broadly-syndicated loans and (2) the adequacy of cash collected from the collateral to pay the interest. Some challenges were also identified: (1) up to 65% of the portfolio pool may consist of Cov-lite Loans and (2) the underlying collateral portfolio may be insufficient to redeem the Notes in an Event of Default.

The transaction is currently failing its WA Rating Test (actual 3160; threshold 3035) and Effective Date Overcollateralization Test (actual 106.59%; threshold 108.70%), as of November 14, 2022. The rest of the Coverage and Collateral Quality Tests, as well as the Concentration Limitation tests, are in compliance. Although failures are observed in the above-mentioned tests, DBRS Morningstar ran the current profile analysis with all the failing levels and the transaction would still withstand the rating stress. There were around $2.98 million in defaulted obligations registered in the underlying portfolio as of November 14, 2022. The Overcollateralization Test would still pass with the defaulted obligations carried at zero value.

DBRS Morningstar modeled the transaction using its proprietary cash flow engine and the DBRS Morningstar CLO Asset model. DBRS Morningstar used its predictive model (the publicly available CLO Asset Model) to determine a ratings-based, pool default rate (the Stressed Default Rate), which can be equated with a certain credit rating. Based on inputs into the predictive model, such as obligor credit quality, obligor and industry diversification, and term to maturity, the predictive model generated a level of cumulative default stress appropriate for each rating category. DBRS Morningstar then performed cash flow analysis using a proprietary cash flow engine, which incorporated inputs such as the Stressed Default Rate as well as assumptions relating to principal amortization, amount of interest-generated, default timing, recoveries, and movement in interest rate curves, among other considerations. The output of this cash flow analysis is referred to as the break-even default rate (BDR).

DBRS Morningstar assigns ratings based on a comparison of the BDR results of the cash flow analysis as it compares to the Stressed Default Rate output from the default probability model. Model-based analysis produced satisfactory results that supported the above assigned ratings on the Notes.

DBRS Morningstar notes that a legal analysis, which included but was not limited to legal opinions and various transaction documents, was performed by Morningstar Credit Ratings, which also engaged external counsel as part of its process of assigning new ratings to the CLOs on or prior to the closing date. DBRS Morningstar did not perform additional legal analysis for the purpose of assigning or monitoring ratings to the Notes, unless otherwise indicated in this press release.

The transaction assumptions consider DBRS Morningstar’s baseline macroeconomic scenarios for rated sovereign economies, available in its commentary “Baseline Macroeconomic Scenarios for Rated Sovereigns: December 2022 Update,” published on December 21, 2022 ( These baseline macroeconomic scenarios replace DBRS Morningstar’s moderate and adverse Coronavirus Disease (COVID-19) pandemic scenarios, which were first published in April 2020.

For more information regarding DBRS Morningstar’s additional adjustment for select industries related to the Coronavirus Disease (COVID-19), please see its May 18, 2020, commentary “CLO Risk Exposure to the Coronavirus Disease (COVID-19)” at

There were no Environmental/Social/Governance factors that had a significant or relevant effect on the credit analysis.

A description of how DBRS Morningstar considers ESG factors within the DBRS Morningstar analytical framework can be found in the DBRS Morningstar Criteria: Approach to Environmental, Social, and Governance Risk Factors in Credit Ratings at (May 17, 2022).

All figures are in U.S. dollars unless otherwise noted.

The principal methodologies are Rating CLOs and CDOs of Large Corporate Credit (January 26, 2022) and Cash Flow Assumptions for Corporate Credit Securitizations (January 26, 2022), which can be found on under Methodologies & Criteria.

The DBRS Morningstar Sovereigns group releases baseline macroeconomic scenarios for rated sovereigns. DBRS Morningstar analysis considered impacts with the baseline scenarios set forth in the following report:

The rated entity or its related entities did participate in the rating process for this rating action. DBRS Morningstar had access to the accounts and other relevant internal documents of the rated entity or its related entities in connection with this rating action.

For more information on this credit or on this industry, visit or contact us at [email protected].

DBRS, Inc.
140 Broadway, 43rd Floor
New York, NY 10005 USA
Tel. +1 212 806-3277